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Cutaneous wound healing is a highly coordinated physiological process that rapidly and efficiently restores skin integrity.
Reepithelization is a crucial step during wound healing, which involves migration and proliferation of keratinocytes to cover the denuded
dermal surface. Recent advances in wound biology clarified the molecular pathways governing keratinocyte reepithelization at wound
sites. These new findings point towards novel therapeutic targets and provide suitable methods to promote faster tissue regeneration in
vivo.
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Skin wound healing represents a dynamic and well-
ordered biological process [1,2]. Tissue injury causes
vascular vessels disruption and extravasation. A temporary
fibrin clot reestablish homeostasis and provides a transient
substrate for platelets that secrete growth factors (GFs),
cytokines and extracellular matrices (ECM). These medi-
ators of the inflammation response recruits macrophages
and neutrophils that secrete a battery of specific factors,
orchestrating the following phase of tissue reepithelization
[3]. Reepithelization is the resurfacing of a wound with
new epithelium and consists of both migration and
proliferation of keratinocytes at the periphery of the
wound.
Migrating keratinocytes undergo subcellular modifica-
tions including (i) disassembly of hemidesmosomal links
between epidermis and BM; (ii) retraction of intracellular
tonofilaments and keratin filaments; (iii) dissolution of most0014-4827/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: msantoro@unipmn.it (M.M. Santoro).desmosomes; (iv) formation of peripheral cytoplasmic actin
filaments (lamellipodia) and focal contacts [4].
As epidermal migration moves on, keratinocytes at the
wound margin begin to proliferate behind the actively
migrating cells. The resulting dense hyperproliferative
epithelium feeds the migrating sheets at the wound margins
[5]. These events are regulated by the crosstalk of three
main molecular actors: GFs, integrins and metalloproteases
(MMPs) (Fig. 1).
Activation of integrin receptors by migrating keratino-
cytes allows the interaction with a variety of ECM proteins
interspersed in the provisional wound bed and at the wound
margin. Moreover, expression and activation of MMPs
promotes degradation and modification of extracellular
matrix proteins at the wound site, facilitating cell migration
[6]. Then, BM proteins reappear in a very ordered sequence
from the margin of the wound inward, in a zipper-like
fashion. Epidermal cells revert to their normal phenotype,
once again firmly attached to the reestablished BM and
underlying dermis.
Here we report the molecular and cellular mechanisms
that regulate keratinocyte reepithelization at wound sites.
Genes regulating keratinocyte migration and proliferation
during reepithelization, orchestrate growth factor receptors,h 304 (2005) 274–286
Fig. 1. GFs, ECM, integrins and MMPs involved in the migration and proliferation of skin keratinocytes at wound sites. Hematoxylin–eosin staining of mouse
skin section during the reepithelization process (see text for details).
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loproteases (MMPs) in the cooperative effort of wound
healing and skin regeneration.Molecular and cellular events during keratinocyte
migration at wound sites
In normal skin, keratinocytes are assembled in a
quiescent epidermal tissue, tied up by cell junctions, which
include desmosomes at cell–cell contacts and hemidesmo-
somes (HDs) at cell–substrate contacts (Fig. 1). Desmo-
somes are one of the most abundant types of cell–cell
junctions in epidermis [7]. In keratinocytes of confluent cell
sheets (resting phenotype), desmosomes are Ca2+-independ-
ent, by contrast to those of subconfluent epidermal cells
(motile phenotype) that become Ca2+-dependent [8,9].
PKCa plays a key role in the rapid conversion from Ca2+-
independent to Ca2+-dependent desmosomes, and is
required to allow cell–cell dissociation, as part of the
signaling pathway modulating desmosomal adhesion in
response to wounding [10].
HDs are specialized cell–ECM junctions stabilizing
adhesion of epithelial cells to the underlying BM. HD
nucleation is triggered by binding of a6h4 integrin to
laminin-5 and by following organization of a multiprotein
intracellular complex [11]. The critical role for HDs stems
from its ability to assemble stable and rigid structures at the
basal cell surface, by linking the intermediate keratin
filament cytoskeleton with the BM [12]. The importance
of HDs for epithelium integrity is highlighted by the
devastating blistering skin disease junctional epidermolysisbullosa (JEB), linked to mutations in the genes encoding the
protein component of the HD [13–15].
Integrins and extracellular matrices (ECM)
To heal an injured skin epithelium, cells undergo HD
dissociation, to release the contacts with BM and cell–
substrate contacts reorganization, to allow migration.
Critical for modulating HD and focal contacts are integrins,
a–h heterodimeric transmembrane cell surface receptors,
which bind ECM proteins via the extracellular portion and
interact with cytoskeletal structures via the intracellular
regions [16]. Eighteen a and eight h chains are encoded by
different genes and each a–h array defines its own binding
specificity and signaling properties [17,18]. To date, at least
24 ah different heterodimers, composed by 18 different a
and 8 different h subunits, are known [16]. Many integrins
have overlapping ligand-binding functions and certain cell
types can express more than one of the integrins, with the
same ligand-binding specificity, although their signaling
function appear to be different (e.g., keratinocytes can
express at least three different fibronectin receptors, avh1,
avh6 and a5h1). In addition, functional diversity may
result from alternative splicing isoforms of a and h
subunits.
Interaction of integrins with their ECM ligands leads to
receptor clustering and recruitment of multiple intracellular
signaling proteins. Interaction with p130Cas, paxillin,
vinculin, bGTP exchangerQ factors and protein kinases,
such as focal adhesion kinase (FAK) or integrin-linked
kinase (ILK) elicits boutside–inQ signals that promote
lamellipodia, filopodia and actin fibers formation. These
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migrating keratinocytes extend long filopodia/lammelipo-
dia-like cytoplasmic projections in the wound area and use
actin filament to pull wound edge together [19]. On the
other hand, the extracellular binding activity of integrins can
be regulated by binside–outQ signaling [20]. In wound
healing, the intact BM is degraded and migrating keratino-
cytes use a provisional matrix in the wound bed, which is
rich in fibrin, fibronectin, vitronectin and laminin-5. During
reepithelization, keratinocytes makes also contact with
dermal collagens [21].
A mandatory step before keratinocyte migration over the
provisional matrix is HDs disassembly. Integrins detach
from laminin-5 via binside–outQ signaling, releasing basal
localization and connection to the keratin cytoskeleton.
Then, they relocate to F-actin-rich structures, such as
lamellipodia, at the leading edge of migrating keratinocytes
[22]. This mobilization is mediated by PKCa-mediated
serine/threonine phosphorylation of the intracellular portion
of h4. This phosphorylation induces the binding of 14-3-3
proteins to the connecting sequence (CS) of the h4 that
contains putative phosphorylation sites, possibly important
for the biology of a6h4 [23,24]. Several reports show that
phosphorylation of serine/threonine and tyrosine residues
in the h4 CS are critical for HD regulation and disassembly
[24,25]. MSP (Macrophage-Stimulating Protein) and PMA
(Phorbol Myristate Acetate) can modulate PKCa-mediated
a6h4 phosphorylation and HD disassembly, therefore
starting keratinocyte migration [24,26]. It has been sug-
gested that also EGF (Epidermal Growth Factor)-dependent
tyrosine phosphorylation of the h4 cytoplasmic domain
may be a mechanism for HD disassembly. However,
mutation of the major tyrosine phosphorylation sites
provides only a partial protection from EGF-induced HD
disassembly, suggesting the involvement of other concomi-
tant mechanisms [25,27].
Migrating keratinocytes express several ECM receptors
at wound sites, such as the a5h1 fibronectin-binding
integrin, a3h1 and a6h4 integrins both binding laminin-5,
the a2h1 collagen receptor, the avh1 fibronectin receptor,
the avh5 and avh6 vitronectin-binding integrin and the
a9h1 tenascin C receptor [19,28].
Keratinocyte migration
Laminins are large heterotrimeric molecules, composing
the lamina lucida of BM. In particular, laminin-5 is
synthesized, within hours after wounds, by skin keratino-
cytes as a precursor heterotrimeric protein (a3,h3,g2) that
undergoes processing of a3 and g2 subunits after being
secreted [29]. Consistently, while laminin-5 is differentially
expressed during human wound healing, the precursor
laminin-5 is detected in the wound site, but not in the
flanking homeostatic tissue [30]. Moreover, laminin-5
expression is sustained by TGF-h and INFg present in the
wound fluid [31].Current models of wound reepithelization propose that
different cleavage of this type of ECM affect the preference
for interactions with the two laminin-5 integrin receptors,
a3h1 and a6h4. The precursor form of laminin-5 has a
major binding affinity for a3h1, while the processed form
associate preferentially to a6h4. This is the primary
adhesive integrin of the adult epidermal basement mem-
brane (BM) and supports cell adhesion by forming HDs
after laminin-5 binding [11]. On the other hand, a3h1 is
located in focal contacts and regulates cell spreading and
migration [32]. The complementary roles for a6h4 and
a3h1 in keratinocyte reepithelization can be explained
through the control that a6h4 exerts on a3h1 integrin
[23,30]. The interference by a6h4 integrin on a3h1-
mediated migration on laminin-5 has been recently described
in HaCat keratinocytes [33]. This bnegativeQ control by one
integrin on another has been observed also in vivo and is
known as btransdominantQ inhibition [34,35]. When kerati-
nocyte start migrating, a switch from a6h4 to a3h1 integrin
for laminin-5 binding occurs at wound site and, in parallel to
a6h4 phosphorylation (see above), this promotes HD
disassembly and relocation of the a6h4 integrin from HDs
to lamellipodia. Concomitantly, a3h1 becomes bunlockedQ
and move to focal contacts regulating actin-myosin-driven
processes required for cell spreading and migration (Fig. 2).
Accordingly, laminin-5 expression are responsible for a shift
in integrin dominance, hence modulating keratinocyte
migration during skin reepithelization [30] and the interplay
among a3h1, a6h4 and different laminin-5 isoforms is
crucial to lead keratinocytes for recruiting a3h1 at focal
contacts and mediating migration over the provisional
matrix, but also to reform HDs component at later stages
of wound healing [30,31,36,37]. The switch from a6h4 to
a3h1 in migrating keratinocytes does not complete the
overall mechanism. Deposition of precursor laminin-5 is
necessary but not sufficient to stimulate motility via a3h1
integrin and wound closure. Other soluble factors, mainly
growth factors, are possibly present at wound sites to
promote full keratinocyte reepithelization.
While the wounding process goes on, integrin expression
is up-regulated by keratinocytes, which also start to express
novel integrins, including avh6 and avh5. A role for the
fibronectin-binding avh6 integrin in tissue repair and
remodeling has been suggested, but a clear function of
avh6-integrin in wound healing is debated. Increased avh6
expression can be observed in wound keratinocytes, while
in cultured cells avh6-integrin facilitates cell adhesion and
migration on fibronectin, vitronectin and tenascin, which are
components of the early wound provisional matrix [28,38].
Early expression of avh6 integrin during keratinocyte
migration into the wound site suggests that avh6 integrin
may regulate this process also in vivo [2]. However, h6
integrin-deficient mice showed no changes in wound
closure rate [39]. Although avh6 integrin is expressed by
migrating keratinocytes in early wounds, the maximal
expression coincides with the formation of basement
Fig. 2. Schematic representation of the events occurring at molecular level in skin keratinocytes after wounding. (1) Deposition of precursor laminin-5 in the
provisional BM of wounds by leading keratinocytes. (2) Switch of integrin dominance for laminin-5, participation of a2h1, a3h1 and deposition of laminin-5
during migration on collagen. (3) Regulation of adhesion-dependent cell signalling on collagen through deposition of laminin-5 by leading cells. (4) Promotion
of gap junction intercellular communication (GJIC) in following cells by laminin-5. (5) The need for laminin-5 for assembly of HDs in quiescent cells.
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of the wound epithelium have joined. The temporal local-
ization of avh6 integrin in regenerating epithelium suggests
that avh6 integrin may also be involved in epithelial cell
differentiation, regeneration of basement membrane, regu-
lation of inflammatory reaction and formation of granulation
tissue. Interestingly, heterologous expression of avh6 in
oral keratinocytes led to enhanced MMP-9 secretion,
functional in mediating cell migration [40]. The integrin
h5 subunit is known to pair up only with the integrin av
subunit, forming the vitronectin receptor avh5 [41].
Expression of the integrin h5 subunit has been investigated
in cutaneous wound healing and in incisional wounds. In
suction blisters increased immunoreactivity for h5 complex
has been detected in suprabasal cell layers of the regenerat-
ing epidermis [42]. However, as for h6, in h5-deficient
mice, the healing rate of cutaneous wounds is not altered,
although keratinocytes harvested from these mice demon-
strate impaired migration on and adhesion to vitronectin[39]. The expression of the integrin avh5 subunit has been
extensively studied in human cutaneous wound healing.
Increased immunoreactivity for the avh5 complex has been
detected predominantly in basal keratinocytes during exci-
sional wound healing in human skin [2].
Integrins can also associate with several transmembrane
proteins, such as IAPs (integrin-associated proteins), tetra-
span/TM4SF proteins, cell surface proteoglycans and
syndecans [43,44]. All of these proteins may critically
regulate integrin functions especially during keratinocyte
migration. The IAP protein CD98 through the binding to the
a3h1 integrin can regulate its function [45]. The tetraspan-
nin proteins CD151 form a stable complex with a3h1
integrin, which is required for a3h1 function and cell
migration [46–48]. However, it has been found that CD151
can also associate to a6h4 integrins [49]. Another tetra-
spannin protein, CD9, associates with a3h1 in keratinocytes
to form a complex involved in regulating cell motility
[50,51]. Syndecans are transmembrane proteoglycan that
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to a range of extracellular ligands, including growth factors,
integrins and extracellular matrix proteins. Syndecans have
a single transmembrane domain, a short cytoplasmic
domain, and a larger extracellular domain that bears three
to five glycosaminoglycan chains, mostly heparan sul-
fate [52]. Among the four mammalian syndecans, synde-
can-1, -2 and -3 are the major syndecans of epithelial,
fibroblastic and neuronal cells, respectively, whereas syn-
decan-4 is unusual, appearing as an ubiquitous component
of most cells. Engagement of syndecan-4 is essential for
adhesion formation in cells adhering via certain integrins,
and for cell proliferation and migration in response to
growth factors. The cytoplasmic domain of syndecan-4
interacts with a number of signaling and structural proteins,
and syndecans acts as an organizing center for trans-
membrane receptor and is anchored to the actin cytoskeleton
[53]. Hyaluronan is a glycosaminoglycan present in most
extracellular matrices, including that between the vital cells
of the epidermis. It forms a loose, highly hydrated, gel-like
matrix that contributes to the maintenance of the extra-
cellular space and facilitates nutrient diffusion. But it also
works by interacting with specific receptors, such as CD44
and receptor for hyaluronan-associated motility, which
activate intracellular locomotory signals [54]. Hyaluronan
is involved in cell proliferation and differentiation, produces
an environment favorable for migration, and stimulates cell
locomotion. In skin epidermis, the narrow extracellular
space surrounding keratinocytes contains a high concen-
tration of hyaluronan, as do other stratifying squamous
epithelia. Elevated tissue levels of hyaluronan occur during
embryonic growth of tissues and organs and wound healing
[55]. Recently, it has been shown that hyaluronan synthesis
is up-regulated in cultured keratinocytes stimulated to
migrate with EGF and KGF [56,57].
Growth factors and growth factor receptors
Skin injury represent the stimulus starting the migration
of epidermal cells at wound sites and some authors suggest
that the absence of neighbor keratinocytes at the margin of
the wound, due to the mechanical cut off of the epidermal
sheet, may be a signal for migration [4]. During the
inflammatory phase, the local release by plasma, fibroblasts
and macrophages/neutrophils of growth factors appears to
be very important for activating keratinocytes at the wound
margins.
Platelet-derived growth factor (PDGF)
PDGF has been widely recognized as having a signifi-
cant role in the process of wound healing [58]. The role of
PDGF during skin wound healing seems to be related to the
following reepithelization phases of granulation tissue
formation and contraction of the wound. Nanomolar
concentrations of PDGF-BB and, at lesser extent PDGF-
AA, accelerate the formation of granulation tissue both invitro and in vivo [59]. PDGF is a chemotactic factor for cells
migrating into the healing skin wound, such as neutrophils,
monocytes, and fibroblasts [58]. In addition, it enhances
proliferation of fibroblasts and production of extracellular
matrix by these cells during wound contraction and
extracellular matrix reorganization. Finally, it stimulates
fibroblasts to contract collagen matrices and induces the
myofibroblast phenotype in these cells [2]. The patterns of
PDGF and PDGF receptor expression suggest a paracrine
mechanism of action, since the ligands are predominantly
expressed in the epidermis, whereas the receptors are found
in the fibroblast of dermis and granulation tissue. PDGF
may be involved in wound healing abnormalities. In some
individuals, wound healing can lead to hypertrophic scar or
keloid formation, characterized by an overabundant extra-
cellular matrix and consistent with differences in growth
factor profiles of both the epidermis and the dermis.
Immunocytochemical studies revealed that augmented
epidermal PDGF production leads to increased formation
of the dermal matrix in hypertrophic scars [60]. On the other
hand, PDGF and PDGF receptors expression significantly
reduce during wound healing in healing-impaired geneti-
cally diabetic db/db mice, indicating the beneficial effect of
exogenous PDGF in the treatment of wound-healing
disorders [61]. Moreover, human keratinocytes genetically
modified to overexpress PDGF-A, transplanted to full-
thickness excisional wounds on the back of athymic mice,
revealed that PDGF-A overexpression improves graft
performance. This provides a therapeutic application to
increase the performance of bioengineered skin substitutes
as a strategy for skin repair [62]. PDGF is currently
approved for use in human medicine [63].
Epidermal growth factor
A series of experimental and clinical studies have
demonstrated a positive effect of EGF, TGF-a and HB-
EGF on wound repair, suggesting that the endogenous
growth factors are also involved in the healing process
[1,64]. In particular, they are considered as key regulators of
keratinocyte proliferation at wound site, released in abun-
dance at the wound site mainly by eosinophils and macro-
phages. In addition, epidermal keratinocytes at the wound
edge were identified as a source of TGF-a in partial-
thickness murine burn wounds, with maximal levels during
the phase of keratinocyte proliferation. EGF immunoreac-
tivity was found to be associated with the presence of
wound inflammatory cells and wound fibroblasts [65].
Finally, HB-EGF was localized in the advancing epithelial
margin and in marginal surface keratinocytes of murine
partial-thickness burn wounds [66]. Interestingly, HB-EGF
was shown to act synergistically with insulin-like growth
factor (IGF)-1, another growth factor present in wound
fluid, in stimulating keratinocyte proliferation in vitro [67].
EGF, TGF-a and HB-EGF exert their function via binding
to the EGFR, a transmembrane protein tyrosine kinase that
is expressed on many different cell types [68]. Consistent
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EGFR were also detected in the hyperthickened wound
epidermis and in all appendages, but was absent from
leading epithelial margins [69], suggesting a role for the
EGF receptor in transducing a proliferative signaling
response at wound sites during the reepithelization phase.
At least other two growth factors are central players in
this process: TGF-h and MSP.
Transforming growth factor b (TGF-b)
The TGF-h superfamily encompasses a diverse range of
structurally related but functionally distinct mammalian
members, i.e., TGFhs and BMPs. Their biological effects
are mediated by heteromeric receptor complexes [70]. The
TGF-h ligand initiates signaling by binding to type I and
type II receptor serine/threonine kinases on the cell surface
and by high affinity to bnonsignalingQ type III receptor,
which presents TGF-hs to type II receptor [71,72]. This
allows receptor II to phosphorylate the receptor I kinase
domain, which in turn propagates the signal through
phosphorylation of Smad proteins. There are eight Smad
proteins, constituting three functional classes: the receptor-
regulated Smad (R-Smad), the Co-Smad (Co-Smad), and
the inhibitory Smad (I-Smad). R-Smads once phosphory-
lated and activated by the type I receptor kinases undergo
homotrimerization and formation of heteromeric complexes
with the Co-Smad, Smad4. The activated Smad complexes
are translocated into the nucleus and, in conjunction with
other nuclear cofactors, regulate the transcription of target
genes. The I-Smads, Smad6 and Smad7, negatively regulate
TGF-h signaling competing with R-Smads for receptor or
Co-Smads and by targeting the receptors for degradation.
TGFh1 is the most important ligand for starting
migration of skin epithelial cells during the reepithelization
process [73,74]. TGFh1 can inhibit cell proliferation and
start cell migration because it is a potent stimulator of gene
expression, in particular of ECM components, MMPs and
integrins in different target cells [71,75].
Platelets of the blood clot, immediately after wounding,
facilitate the formation of the hemostatic plug and release
large amounts of TGFh1 [76]. This growth factor has two
major target cells: macrophages and keratinocytes. Active
TGFh1 promotes migration and activation of monocyte–
macrophage cells in the wound site for clearance of
microorganisms and ECM fragments. Also, latent TGF-h1
is produced and sequestered within the wound matrix,
allowing a sustained release by proteolytic enzymes. This
combination of different cellular sources and temporary
storage ensures a continuous supply of TGF-h1 throughout
the repair process [73]. Later, TGFh1 stimulates expression
of some integrin subunits that promote keratinocyte migra-
tion on the provisional extracellular matrices of the wound
bed [75,77]. Interestingly, TGF-h was shown to stimulate
angiogenesis, fibroblast proliferation, myofibroblast diffe-
rentiation and matrix deposition, critical for an efficient
reepithelization [73,78]. This is supported by a series ofstudies in several animal models that demonstrate a
beneficial effect of exogenous TGF-h for wound repair, in
terms of both rate of healing and strength of the healed
wound [73].
Interestingly, integrin avh6 can localize transforming
growth factor (TGF)-h1 to cell surface by binding to the
latency-associated peptide leading to TGF-h activation
presumably by a nearby cell. TGF-h1 plays an important
role in wound repair by regulating re-epithelialization,
suppressing inflammation, and promoting connective tissue
regeneration and scar formation. In the absence of avh6
integrin, there seems to be a deficiency of TGF-h1
activation by the epithelium leading to exaggerated inflam-
mation in response to injury or infection. Transgenic mice
with targeted deletion of h6 integrin developed excess of
lung inflammation that was reversed by restoring h6
expression. Moreover, they were compromised in their
ability to produce the inflammatory response to experimen-
tal infection in the gut. Activated TGF-hs may also regulate
other cellular functions critical for wound healing, including
integrin expression, cell migration, proliferation, diffe-
rentiation and, matrix synthesis and degradation, in an
autocrine or paracrine manner [75].
Macrophage stimulating protein (MSP)
MSP belongs to a protein family that includes plasmi-
nogen and HGF. MSP molecule is characterized by
multiple copies of a highly conserved triple disulfide loop,
named bkringleQ [79], and is released by hepatocytes in
circulating blood as a biologically inactive form, pro-MSP.
Pro-MSP is proteolitically processed and activated at
extravascular sites by specific serine proteases, such as
trypsin-like proteases, enzymes of the coagulation cascade
and a specific convertase located on the plasma membrane
of macrophages [80,81]. MSP promotes its effects on target
cells through binding to the Ron tyrosine kinase receptor
[82,83]. MSP stimulation induces Ron dimerization and
receptor autophosphorylation on several critical tyrosine
residues in the kinase domain and in the C-terminal tail,
generating specific-binding sites that interact and recruit
SH2-containing adaptor/docking proteins. Ron activates a
variety of intracellular signaling pathways including Ras/
Erk, PI3K/Akt, JNK, FAK and NF-kB. It is known that
these pathways are essential for cell growth, migration,
survival and differentiation [84,85]. The MSP receptor is
expressed in epithelial tissues, including human foreskin
keratinocytes, and in specific hematopoietic cells [86–91].
Recently, several reports suggest a specific role for MSP
and Ron in wound healing [24,92,93]. The involvement of
MSP-Ron in skin wound repair is supported by several
experimental evidences: (i) MSP, pro-MSP and an MSP
convertase have been found at wound sites in human
wound fluids; (ii) MSP and Ron expression was shown in
full-thickness excision wounds; (iii) Ron is up-regulated in
migrating keratinocytes at the wound edge and in dermal
macrophages; (iv) an autocrine loop of MSP is observed in
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in vitro; (v) wound treatment with exogenous MSP
enhance reepithelization in mice; (vi) Ron promotes
primary keratinocyte reepithelization and activate a specific
gene expression program necessary to support full wound
closure. The role of MSP and Ron in wound healing has
been clarified at molecular level (Figs. 2 and 3). In basal
keratinocytes normally expressing Ron, MSP-mediated
activation of Akt and PKC protein kinases promote serine
phosphorylation of both Ron and a6h4 receptors, generat-
ing in both molecules 14-3-3 binding sites. Due to their
dimeric structure, 14-3-3 proteins promote the formation of
a Ron-a6h4 complex, which reduced laminin5-a6h4
affinity and disassemble HD structures. These molecular
events block a6h4 transdominant function promoting a3b1
integrin activation and keratinocyte migration at the wound
sites. Finally, Ron activation and 14-3-3 binding are
responsible for a shift in integrin dominance, hence
modulating keratinocyte migration during skin reepitheli-
zation [24].
MSP/TGFb1 synergism
Recent studies demonstrated that Ron activation results
in increased expression of the Smad 2 proteins and directly
causes its phosphorylation [85]. Smad 2 is a signal molecule
responsible for TGF-h-induced EMT function [72]. The fact
that Ron activation mediates Smad 2 expression and
phosphorylation suggests that in epithelial cells exist a
Ron-mediated TGF-h/Smad signaling pathway. Our recent
studies further demonstrated that keratinocytes stimulationFig. 3. MSP promotes wound healing in vivo. Full-thickness wounds treated with
day 4 after MSP treatment. The scale bar represents 1 mm. (C) Reepithelization c
presented.by MSP and TGF-h1 results in increased migration rate and
EMT transition during in vitro wound healing assays
(Santoro MM, unpublished results). Since both MSP and
TGF-h are involved in regulating epithelial wound healing
in vivo, the synergism in signaling between Smads and Ron
might be essential in regulating migration of keratinocytes
during reepithelization, as well as promotes de novo
expression of integrin, ECM and MMP at wound site.
Small GTPases
Homeostasis of normal tissues require the regulation of
actin cytoskeleton and of adhesive properties, which are
both deeply influenced by the Rho family GTPases and their
effectors [94]. The Rho family proteins are central regulators
of cell protrusions and cell polarity, controlling the
formation of lamellipodia and filopodia, by interactions
with different downstream effectors, which are protein and
lipid kinases, as well as activators of the Arp2/3 complex
[95]. For instance, the balance between proliferation and
differentiation in human keratinocytes has been related to
the activity of the GTP-binding protein RhoA, through its
signal mediators ROCK serine/threonine kinases: ROCK-I
and ROCK-II. Pharmacological inhibition of ROCK blocks
primary human keratinocyte terminal differentiation and
induces cell proliferation. In contrast, activation of ROCK-II
by expressing a conditionally active form of ROCK-II
results in cell cycle arrest and an increase in the expression
of a number of genes associated with terminal differentiation
[96].PBS + matrigel (A) with MSP + matrigel (B). (A, B) Wound appearance at
ompletes after 10 days in MSP-treated wound. Representative pictures are
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keratinocyte reepithelization involves the expression of
extracellular metalloproteinases such as MMP-2 MMP-9,
whose activity is required for cell migration and extra-
cellular matrix remodeling. During response to keratinocyte
injury, MM-9 is up-regulated upon the mechanical stress
created by injury itself and depends by a cross-talk between
signaling of RhoGTPases, p38[MAPK] and JNK. In partic-
ular, Rac1 and/or Cdc42 control the activation of p38[MAPK],
while RhoA activity leads to stimulation of JNK [97].
Moreover, the role of small GTPases in keratinocyte
reepithelization is confirmed by the role in a6h4 regulated
keratinocyte chemotaxis. a6h4 integrin and laminin-5
interaction drives chemotaxis by sustained activation of the
Rho family GTPase Rac1, possibly via activation of
Phosphoinositide-3-kinase (PI3-K) [98] and redirection of
a3h1 away from basal focal contacts. In absence of a6h4
activation, chemotaxis is mediated by an alternative pathway
based on RhoA activity [99].
Matrix metalloproteinases
MMPs are a family of zinc-dependent enzymes whose
catalytic activity is tightly regulated: They are secreted as
inactive proenzymes (zymogens) and the activation occurs
in the extracellular compartment [100]. In general, MMPs
are not expressed constitutively in vivo, but are tightly
regulated at the transcriptional and post-transcriptional
levels as well as controlled at the protein level via
activators, tissue-derived inhibitors (TIMPs) and cell surface
localization [6].
During wound healing, degradation of ECM components
by MMPs is required to remove and reorganize provisional
matrices and to allow cell migration [37] and basal
keratinocytes at the migrating front of reepithelization are
the predominant source of MMPs. Human keratinocytes
synthesize and secrete mainly MMP-1, MMP-2, MMP-9
and MMP-10, and this expression is required to regenerate
the injured tissue.
Following injury, MMP-1 is consistently expressed by
migrating keratinocytes bordering the wounds, but it is not
express by proliferating keratinocytes [101]. MMP-1
expression is abundant at the wound edge and progressively
decreases away from it [102]. It has been demonstrate that
both TNF-a and TGF-h1 induce in vitro expression of
MMP-1 in keratinocyte via a p38-dependent pathway [103].
In keratinocytes, MMP-1 expression is driven by contact
with type-I collagen, mediated by a2h1 integrin [104]. In
reepithelization, keratinocytes migrate over the dermal
connective tissue, composed mainly by type I collagen,
and lose contacts with BM, due to injury-mediated BM
disruption. Loss of contact with BM and the interaction with
type I collagen in the dermis promote a2h1 integrin-
mediated MMP-1 expression in migrating keratinocytes. In
turn, MMP-1 expression sustains keratinocytes migration on
type I collagen, also associating MMP-1 it self and a2h1integrin. This interaction provides a molecular mechanism
for bridging together matrix, integrin and the protease. This
results in controlled and localized proteolysis at the injury
site, facilitating cell migration [104,105]. Laminin-1, but not
laminin-5, appears to be able to down-regulate MMP-1
expression in migrating keratinocytes. An intriguing possi-
bility is that deposition of laminin-1 during BM reorganiza-
tion is the signal conveyed to keratinocytes, to suppress
MMP-1 expression and motility.
Both MMP-2 and MMP-9 play an important role in
wound healing. MMP-2 expression is modulated in kerati-
nocytes by TGF-h1 and MSP [24,106]. Expression of
MMP-2 remains stable at wound healing, suggesting a role
during the prolonged remodeling phase, by proteolysis of
laminin-5 that modulates keratinocyte migration [107]. The
cleavage of laminin-5 by MMP-2 generates an EGF-like
fragment promoting cell migration on epidermal cells [108].
MMP-9 is expressed at wound sites by migrating keratino-
cytes and macrophages. In keratinocytes, MMP-9 is con-
stitutively expressed, but can be up-regulated by TGF-h,
TNFa and IL1h stimulation [109]. MMP-9 can activate
inactive TGF-h ligands, generating a positive loop that
sustains keratinocytes migration [110]. Finally, MMP-10 is
expressed by migrating keratinocytes at the migratory front
of the epithelium, where it colocalizes with MMP-1 [111].
MMP-10 appears to assist keratinocyte migration at the
epithelial front and also contributes to remodeling of the
newly formed matrix. MMP-10 can also activate MMP-9.
In summary, MMP activity has the potential to induce
migration, but also to reverse the function of the matrix
molecules and growth factors from stimulating migration to
supporting stable anchorage. For these reasons, imbalance
expression of MMPs at wound sites may contribute to the
pathogenesis of poorly healing wounds [37].Keratinocyte proliferation at wound sites
During the step of reepithelization, keratinocytes both
migrate to cover the wound and proliferate to form a dense
hyperproliferative epithelium feeding the epithelial tongue.
To reconstitute full thickness skin and tissue integrity,
proliferation is sustained by growth factors, in turn assisted
by integrins and MMPs [112].
It is well established that three growth factors, (i) EGF
(Epidermal Growth Factor), (ii) TGFa (Transforming
Growth Factor-a) and (iii) KGF (Keratinocyte Growth
Factor), are central players in the proliferation process [5].
Both EGF and TGFa, belonging to the EGF superfamily,
are abundantly released at wound sites as key regulators of
keratinocyte proliferation [113]. Eosinophils, macrophages
and epidermal keratinocytes at the wound edge have been
identified as sources of EGF and TGFa at maximal levels
during the phase of keratinocyte proliferation [66]. EGF and
TGFa exert their function via binding to the EGFR present
in healing wounds and in particular in hyper thickened
M.M. Santoro, G. Gaudino / Experimental Cell Research 304 (2005) 274–286282wound epidermis as well in all appendages, albeit it is
absent from leading epithelial margins [69].
Another important epidermal wound regulator is KGF (or
FGF7), which acts on keratinocytes in wound healing
through specific interactions with the FGFR2 splicing
variant FGF2IIIb [114]. FGF7 is 100-fold up regulated
within 24 h after wounding in dermal fibroblasts adjacent to
the wound and in fibroblasts of the granulation tissue [115].
Exogenous KGF applied to skin wounds shows mitogenic
activity on healing epidermis [116]. In addition, gyT cell
receptor-bearing dendritic epidermal T cells (DETCs) were
recently identified as a major source of FGF7 in murine skin
wounds [117]. FGFR2IIIb, the only high-affinity receptor
for FGF7, is expressed in keratinocytes of the normal and
wounded epidermis of murine and human wounds in
addition to ligands [115,118].
Furthermore, the GM-CSF cytokine has been demon-
strated to promote keratinocyte proliferation as an important
step during wound reepithelization [119]. Several studies
demonstrated a strong increase in GM-CSF levels of skin
extracts after generation of full-thickness excision wounds,
suggesting a role in cutaneous wound repair for this cytokine
[120]. Furthermore, transgenic mice overexpressing GM-
CSF in the epidermis displayed accelerated wound reepithe-
lization, as a result of increased keratinocyte proliferation
[120,121].
Recently, it has been clarified that the role of growth
factors and their receptors in promoting keratinocyte
proliferation during wound reepithelization can be greatly
influenced by integrins, ECM and MMPs. In particular,
integrins and ECM can positively or negatively regulate
growth factor receptor signaling. Integrin engagement by
ECM can modulate growth factor signaling pathways,
increasing the activity of growth factor receptor and their
downstream intracellular mediators, leading to enhancement
of their biological effects [122]. Integrins and growth factor
receptors can cooperate at the signaling level, but they may
also form macromolecular complexes on the cell membrane
of epidermal cells [123–128]. Integrin association with
Receptor Tyrosine Kinases (RTKs) might protect the latter
against phosphatase activity and/or ensure the correct
subcellular juxtaposition of cytoplasmic tails of the dimeri-
zed receptors. Moreover, trans-phosphorylation among the
two molecules occurs [27,124,128]. In the context of wound
healing, the synergy between integrin, ECM and growth
factors is probably a key process in the regulation of
epidermal proliferation and cell cycle progression. It is well
established that cell cycle G1 progression and cell prolif-
eration require both cell adhesion and interaction with
extracellular matrix (ECM) proteins, as well as stimulation
by growth factors. It has been proved that ECM can
modulate keratinocytes sensitivity to soluble mitogens and
regulate their proliferation [129,130].
Normal cells require matrix attachments not only to
proliferate, but also to protect themselves against anoikis, a
form of apoptotic cell death occurring upon loss of matrixattachment. It is clear that Ras/Erk and PI3K/Akt pathways
activation provides the route eliciting resistance to anoikis
[131]. In keratinocytes, MSP elicits anti-apoptotic effect
both via Erk and PI3-kinase/Akt pathways [91]. Laminin-5
is required for keratinocyte migration, but also for cell
survival at wound site. Accordingly, laminin-5 null
keratinocytes display reduced motility and fail to survive
in culture [132,133]. Since both integrin a6h4 [134] and
a3h1 [135] have been linked to the Ras/Erk signaling
pathway and cell-cycle regulation, laminin-5 may contri-
bute to survival through one or both of these pathways.
Consistently, h4 mutant mice show signs of apoptosis in
epithelial cells [136] and display proliferative defects that
are characterized by increased levels of the cyclin-depen-
dent kinase inhibitor p27 [137]. ECM and BM contain
inactive growth factors bound to the matrix molecules. At
wound sites, the ECM-bound growth factor may be
released form the matrix by proteases that can also cleave
growth factor receptors on the cell surface. These processes
provide important examples for spatial and temporal
control of the release and activation of growth factor
during regeneration of epithelial cells. For example, FGF-2,
which is normally associated with cell-surface or BM
heparin sulfate proteoglycans, must be processed by
proteases to become biologically active for cell prolifera-
tion. It has been found that MMP-2 and plasmin can release
FGF-2. MMP-2 can also cleave the extracellular domain of
the FGFR-1 and contribute to modulate the mitogenic
properties of FGFs [138]. MMP-3 is expressed by
proliferating keratinocytes distal to the wound edge and
from dermal fibroblasts [111]. The role of MMP-3 in
wound repair has been evaluated in MMP-3 knockout mice,
which show impaired skin wound healing [139]. Interest-
ingly, MSP stimulation of primary keratinocyte promotes
de novo MMP-3 expression in these cells via p38- and NF-
nB-dependent pathways [24].
During reepithelization, the proteolytic activity may also
release growth factors already stored in the extracellular
matrix. Specific MMPs have also the capacity to cleave
IGF-1 and TGF-h1 to increase availability of these growth
factors during wound-healing [140,141]. Furthermore, the
role of epidermal stem cells is currently under investigation
during wound healing as a new way to reconstitute skin
integrity after wound healing [142].Conclusions
Here we report the molecular and cellular mechanisms
that regulate keratinocyte biology at wound sites. The
coordinated interactions among integrins, extracellular
matrix molecules, metalloproteases and growth factor
receptors play a key role in wound healing in particular in
the reepithelization phase. Further elucidation and improve-
ment of cellular and molecular mechanisms governing
keratinocyte reepithelization are essential to establish
M.M. Santoro, G. Gaudino / Experimental Cell Research 304 (2005) 274–286 283therapeutic targets and methods to improve tissue regenera-
tion during skin wound healing.References
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